Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 5
2008 4
2009 2
2012 1
2014 1
2016 3
2017 8
2018 8
2019 7
2020 6
2021 7
2022 4
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators. Hadoux J, et al. N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870969 Clinical Trial.
Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE).
Higashiyama T, Sugino K, Hara H, Ito KI, Nakashima N, Onoda N, Tori M, Katoh H, Kiyota N, Ota I, Suganuma N, Hibi Y, Nemoto T, Takahashi S, Yane K, Ioji T, Kojima S, Kaneda H, Sugitani I, Tahara M. Higashiyama T, et al. Among authors: suganuma n. Eur J Cancer. 2022 Sep;173:210-218. doi: 10.1016/j.ejca.2022.06.044. Epub 2022 Aug 3. Eur J Cancer. 2022. PMID: 35932627 Clinical Trial.
Efficacy of Clinical Guidelines in Identifying All Japanese Patients with Hereditary Breast and Ovarian Cancer.
Haneda E, Sato A, Suganuma N, Sebata Y, Okamoto S, Toda S, Kohagura K, Matsubara Y, Sugawara Y, Yamanaka T, Yamashita T, Shimizu S, Narimatsu H. Haneda E, et al. Among authors: suganuma n. Int J Environ Res Public Health. 2022 May 19;19(10):6182. doi: 10.3390/ijerph19106182. Int J Environ Res Public Health. 2022. PMID: 35627717 Free PMC article. Review.
Non-functioning parathyroid carcinoma: a case report.
Suganuma N, Iwasaki H, Shimizu S, Yoshida T, Yamanaka T, Kojima I, Yamazaki H, Toda S, Nakayama H, Masudo K, Rino Y, Kawachi K, Miyagi Y, Miyake A, Ohashi K, Masuda M. Suganuma N, et al. Surg Case Rep. 2017 Dec;3(1):81. doi: 10.1186/s40792-017-0357-4. Epub 2017 Jul 19. Surg Case Rep. 2017. PMID: 28726134 Free PMC article.
Potential Risk Factors for Nivolumab-induced Thyroid Dysfunction.
Yamazaki H, Iwasaki H, Yamashita T, Yoshida T, Suganuma N, Yamanaka T, Masudo K, Nakayama H, Kohagura K, Rino Y, Masuda M. Yamazaki H, et al. Among authors: suganuma n. In Vivo. 2017 Nov-Dec;31(6):1225-1228. doi: 10.21873/invivo.11195. In Vivo. 2017. PMID: 29102951 Free PMC article.
A Large Substernal Goiter that Extended to Both Sides of the Thorax.
Nakayama H, Goda M, Kohagura K, Suganuma N, Iwasaki H, Yamazaki H, Toda S, Masudo K, Rino Y, Masuda M. Nakayama H, et al. Among authors: suganuma n. Case Rep Surg. 2018 Nov 5;2018:6107982. doi: 10.1155/2018/6107982. eCollection 2018. Case Rep Surg. 2018. PMID: 30533243 Free PMC article.
Parathyroid carcinoma with pancreatitis causing hypercalcaemic emergency treated with extracorporeal membrane oxygenation-assisted parathyroid resection.
Toyoda M, Suganuma N, Takahashi A, Masuda T, Goda M, Yoshida T, Yukawa N, Yamanaka S, Rino Y, Masuda M. Toyoda M, et al. Among authors: suganuma n. Endocrinol Diabetes Metab Case Rep. 2023 Jan 5;2023(1):22-0323. doi: 10.1530/EDM-22-0323. Endocrinol Diabetes Metab Case Rep. 2023. PMID: 36606579 Free PMC article.
59 results